Feedback / Questions
pegozafermin (BIO89-100) - 89Bio
https://www.biospace.com/article/releases/89bio-announces-additional-data-from-the-enliven-phase-2b-trial-of-pegozafermin-in-patients-with-compensated-cirrhotic-f4-nonalcoholic-steatohepatitis-nash-at-aasld-the-liver-meeting-2023/
Nov 18, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next